Enhanced Efficacy of Combination of Gemcitabine and Phosphatidylserine-Targeted Nanovesicles against Pancreatic Cancer
Kombo F. N’Guessan1,2, Harold W. Davis1, Zhengtao Chu1, Subrahmanya D. Vallabhapurapu1, Clayton S. Lewis1, Robert S. Franco1, Olugbenga Olowokure1, Syed A. Ahmad3, Jen Jen Yeh4, Vladimir Y. Bogdanov1, Xiaoyang Qi1,2,5,6
1Division of Hematology/Oncology, Department of Internal Medicine, University of Cincinnati College of Medicine, Cincinnati, OH 45267, USA
2Department of Pathology and Laboratory Medicine, University of Cincinnati College of Medicine, Cincinnati, OH 45267, USA
3Department of Surgery, University of Cincinnati College of Medicine, Cincinnati, OH 45267, USA
4Lineberger Comprehensive Cancer Center, Departments of Surgery and Pharmacology, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA
5Division of Human Genetics, Department of Pediatrics, University of Cincinnati College of Medicine and Cincinnati Children’s Hospital and Medical Center, Cincinnati, OH 45267, USA
6Department of Biomedical Engineering, College of Engineering and Applied Science, University of Cincinnati, Cincinnati, OH 45221, USA
Tài liệu tham khảo
Thông tin
Thông tin xuất bản
Molecular Therapy
Tập 28
1876-1886
Thông tin tác giả